| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 18,000 | $37.98 | $683,634.00 | -7.7% | |
| Jul 21, 2015 | PAHC Phibro Animal Health Corp | Carlson Gerald K | Chief Operating Officer | Sell | 16,000 | $38.06 | $609,012.80 | -100% | |
| Jul 20, 2015 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 234 | $34.50 | $8,073.00 | - | |
| Jul 17, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Shohet Stephen B. | Director | Sell | 7,692 | $17.41 | $133,923.10 | -38.7% | |
| Jul 17, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Zasloff Michael A53 | Director | Sell | 7,692 | $17.41 | $133,900.03 | -22.6% | |
| Jul 16, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Patrick Gregory S | VP, Chief Financial Officer | Sell | 6,217 | $20.00 | $124,340.00 | -45.8% | |
| Jul 15, 2015 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 3,566 | $14.26 | $50,844.03 | - | |
| Jul 15, 2015 | PCRX Pacira Biosciences, Inc. | Stack David M67 | President, CEO And Chairman | Sell | 15,000 | $67.78 | $1,016,700.00 | -98.8% | |
| Jul 15, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 18,000 | $38.13 | $686,394.00 | -8.3% | |
| Jul 15, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 18,000 | $38.13 | $686,394.00 | -8.3% | |
| Jul 14, 2015 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 48,472 | $14.32 | $694,194.43 | -0.5% | |
| Jul 13, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Schwabe Stefan K.F. | Executive Vice President R&D | Sell | 1,950 | $19.23 | $37,498.50 | -69.8% | |
| Jul 13, 2015 | EBS Emergent Biosolutions Inc. | Richard Ronald | Director | Sell | 4,922 | $34.00 | $167,348.00 | -20.9% | |
| Jul 9, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 18,000 | $36.90 | $664,212.00 | -7.7% | |
| Jul 9, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 18,000 | $36.90 | $664,212.00 | -7.7% | |
| Jul 2, 2015 | AKBA Akebia Therapeutics, Inc. | Hadas Nicole R.60 | SVP, General Counsel, Sec. | Sell | 1,484 | $9.54 | $14,160.48 | -2.2% | |
| Jul 2, 2015 | AKBA Akebia Therapeutics, Inc. | Nash Duane | Director | Sell | 996 | $9.53 | $9,489.89 | -3.0% | |
| Jul 2, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 19,000 | $38.02 | $722,414.00 | -8.2% | |
| Jul 2, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 19,000 | $38.02 | $722,414.00 | -8.2% | |
| Jul 1, 2015 | EGRX Eagle Pharmaceuticals, Inc. | Tarriff Scott | President And CEO | Sell | 135,710 | $46.34 | $6,288,854.74 | -1.7% | |
| Jun 30, 2015 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 35,000 | $7.90 | $276,500.00 | +3.0% | |
| Jun 29, 2015 | EBS Emergent Biosolutions Inc. | Richard Ronald | Director | Sell | 4,923 | $32.76 | $161,277.48 | -17.3% | |
| Jun 26, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 36,000 | $36.37 | $1,309,200.20 | -26.9% | |
| Jun 26, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 36,000 | $36.37 | $1,309,200.20 | -26.9% | |
| Jun 23, 2015 | PAHC Phibro Animal Health Corp | Carlson Gerald K | Chief Operating Officer | Sell | 16,000 | $36.56 | $584,965.60 | -100% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.